Key facts
- This page summarizes Moshe Shvets's Form 4 filing for Dror Ortho-Design, Inc. (DROR).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 27 Sep 2023, 21:31.
Moshe Shvets - 14 Aug 2023 Form 4 Insider Report for Dror Ortho-Design, Inc. (DROR)
- Reporting relationship
- Chief Technology Officer, Director
- Issuer ticker
- DROR
- Reported as of
- 14 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Sep 2023, 21:31:05 UTC
- Next SEC filing
- 25 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Moshe Shvets
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Moshe Shvets filed Form 4 for Dror Ortho-Design, Inc. (DROR) on 27 Sep 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NVNT
transaction
Derivative
Series A Convertible Preferred Stock
Award
- Transaction value
- Shares
- +691,621
- Change %
- Price
- Shares after
- 691,621
- Date
- 14 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 69,162,094
- Exercise price
- $0.0110
- Footnotes
- F1, F2, F3
NVNT
transaction
Derivative
Common Warrants
Award
- Transaction value
- Shares
- +26,141,712
- Change %
- Price
- Shares after
- 26,141,712
- Date
- 14 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,141,712
- Exercise price
- $0.0330
- Footnotes
- F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock.
Footnote F2
The Preferred Stock is perpetual and therefore has no expiration date.
Footnote F3
Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 18,808 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange").
Footnote F4
Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date").
Footnote F5
Warrants expire on the fifth anniversary of the Initial Exercise Date.
Footnote F6
Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 7,109 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange").